A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
BigHat Biosciences, Inc.
Turning Point Therapeutics, Inc.
Revolution Medicines, Inc.
Erasca, Inc.
Merck Sharp & Dohme LLC
Intima Bioscience, Inc.
Revolution Medicines, Inc.
DualityBio Inc.
Lumicell, Inc.
Zhejiang Doer Biologics Co., Ltd.
DualityBio Inc.
GlaxoSmithKline
BicycleTx Limited
Revolution Medicines, Inc.
Bolt Biotherapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Imugene Limited
Binhui Biopharmaceutical Co., Ltd.
NantBioScience, Inc.
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.
InnoPharmax Inc.
Revolution Medicines, Inc.
Isofol Medical AB
Isofol Medical AB
Isofol Medical AB
Mirror Biologics, Inc.
Repos Pharma
Generic Devices Consulting, Inc.
Mirror Biologics, Inc.
FeRx